GO:0070269 pyroptotic inflammatory response: Gasdermin-Dependent Cell Death Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070269 (pyroptotic inflammatory response) is a gasdermin-dependent inflammatory response associated with the generation of pyrogenic mediators such as IL-1beta and IL-18.
• Gasdermins are activated by caspase-1 or caspase-4/11, or by certain granzymes, and in some but not all cells this leads to pyroptotic programmed cell death.
• The pathway is a central innate immune mechanism that bridges inflammasome sensing to lytic cell death and cytokine release.
• Dysregulated pyroptosis contributes to inflammatory diseases, tissue damage, and cancer, making it a major therapeutic target.
• Key molecular players include NLRP3, caspase-1, GSDMD, GSDME, IL-1beta, and IL-18, which are widely studied using CRISPR knockout and knock-in models.
• Emerging evidence shows that gasdermin D pore blockers and caspase-8-dependent pathways can modulate pyroptosis, offering new intervention strategies.
Description
The pyroptotic inflammatory response (GO:0070269) is a gasdermin-dependent inflammatory response that is associated with the generation of pyrogenic mediators such as IL-1beta and IL-18. Gasdermins are activated by caspase-1 or caspase-4/11, or by certain granzymes, and in some, but not all cells, it can lead to pyroptotic programmed cell death. This process is a cornerstone of innate immunity, linking inflammasome assembly to the release of pro-inflammatory cytokines and lytic cell death. Researchers study GO:0070269 because it is implicated in a wide range of pathologies, including inflammatory diseases, cancer, and tissue damage. Understanding its molecular regulation is essential for developing targeted therapies that can either amplify pyroptosis for tumor control or dampen it to prevent excessive inflammation.
pyroptotic inflammatory response At A Glance
| GO ID | GO:0070269 |
|---|---|
| GO term | pyroptotic inflammatory response |
| Ontology | biological_process |
| Synonym | pyroptosis |
| Definition | A gasdermin-dependent inflammatory response that is associated with the generation of pyrogenic mediators such as IL-1beta and IL-18. Gasdermins are activated by caspase-1 or caspase-4/11, or by certain granzymes. In some, but not all cells, it can lead to pyroptotic programmed cell death. |
| Major function | Innate immune inflammatory response and programmed cell death |
| Key mediators | IL-1beta, IL-18, gasdermins (GSDMD, GSDME) |
| Activating enzymes | Caspase-1, caspase-4/11, certain granzymes |
| Cellular outcome | Pyroptotic programmed cell death (in some cells) |
What Is GO:0070269?
According to the Gene Ontology, GO:0070269 (pyroptotic inflammatory response) is defined as a gasdermin-dependent inflammatory response that is associated with the generation of pyrogenic mediators such as IL-1beta and IL-18. Gasdermins are activated by caspase-1 or caspase-4/11, or by certain granzymes. In some, but not all cells, it can lead to pyroptotic programmed cell death. The synonym for this term is pyroptosis.
Why Is pyroptotic inflammatory response Important in Cell Biology?
GO:0070269 is critically important because it represents a central mechanism by which the innate immune system responds to infection and danger signals, and its dysregulation is directly linked to a broad spectrum of human diseases. The pathway drives the release of pyrogenic cytokines IL-1beta and IL-18, which are key mediators of fever and inflammation, and it can culminate in lytic cell death that amplifies tissue damage. Understanding this process at the molecular level is essential for developing therapeutics that can modulate inflammation in conditions such as sepsis, autoimmune diseases, and cancer.
• GO:0070269 is a major innate immune pathway that links inflammasome sensing to cytokine release and cell death.
• It is a key driver of inflammatory diseases and tissue damage when dysregulated.
• The pathway plays a dual role in cancer, where pyroptosis can either suppress or promote tumor progression depending on context.
• Gasdermin D pore formation is a critical executioner step and a promising drug target.
• Caspase-8-dependent pyroptosis represents an alternative activation route with implications for IL-1beta maturation.
• Mitochondrial DNA release can trigger cGAS-STING-NLRP3-dependent pyroptosis, linking cellular stress to inflammation.
• The ribotoxic stress response can drive acute inflammation and cell death via pyroptosis-related mechanisms.
• CRISPR-based models are essential for dissecting the genetic control of pyroptosis.
• Biomarkers of pyroptosis are being explored for diagnosis and prognosis in inflammatory diseases.
• Therapeutic modulation of pyroptosis is a rapidly growing area in drug discovery.
What Happens During pyroptotic inflammatory response?
Inflammasome Activation and Caspase-1 Recruitment
In simple terms: The cell senses danger and assembles a molecular alarm clock called the inflammasome.
The pyroptotic inflammatory response is initiated when cytosolic pattern recognition receptors detect pathogen-associated or damage-associated molecular patterns, leading to inflammasome assembly. The inflammasome serves as a platform for the activation of caspase-1, which is a key protease in this pathway. This step is tightly regulated and represents the first committed step toward gasdermin activation and cytokine maturation.
Gasdermin Cleavage and Pore Formation
In simple terms: Caspases cut gasdermin proteins, which then punch holes in the cell membrane.
Activated caspase-1 cleaves gasdermin D (GSDMD), releasing its N-terminal pore-forming domain that inserts into the plasma membrane to form pores. Alternatively, caspase-4/11 can directly activate gasdermins in response to cytosolic lipopolysaccharide. Certain granzymes can also activate gasdermins, providing additional routes to pyroptosis. These pores disrupt ionic gradients and lead to cell swelling and lysis.
IL-1beta and IL-18 Maturation and Release
In simple terms: The cell releases powerful inflammatory signals that call immune cells to the site.
Caspase-1 also cleaves pro-IL-1beta and pro-IL-18 into their mature forms, which are then released through gasdermin pores. These pyrogenic mediators amplify the inflammatory response by recruiting and activating immune cells. The release of IL-1beta and IL-18 is a hallmark of the pyroptotic inflammatory response and distinguishes it from other cell death modalities.
Pyroptotic Cell Death and Membrane Rupture
In simple terms: The cell ultimately bursts, spilling its contents and further driving inflammation.
In many cell types, gasdermin pore formation leads to osmotic lysis and a lytic form of programmed cell death known as pyroptosis. This process is distinct from apoptosis and is characterized by membrane rupture and release of intracellular contents. However, in some cells, gasdermin activation may not lead to cell death, highlighting context-dependent outcomes.
Alternative Activation by Caspase-8 and Other Proteases
In simple terms: Other enzymes can also trigger this pathway under certain conditions.
Recent studies have shown that caspase-8 can cleave gasdermin D and drive lytic pyroptosis and IL-1beta maturation, particularly in settings where TNF signaling switches efferocytosis to pyroptosis. This alternative route expands the repertoire of signals that can initiate GO:0070269. Additionally, the ribotoxic stress response can drive acute inflammation and cell death in vivo, further illustrating the diversity of triggers.
Key Genes Involved in GO:0070269 pyroptotic inflammatory response
The following genes and proteins are central to the initiation, execution, and regulation of the pyroptotic inflammatory response (GO:0070269).
| Gene | Major Role | Research Relevance |
|---|---|---|
| NLRP3 | Inflammasome sensor that activates caspase-1 | Target for inflammatory disease and cancer studies |
| CASP1 | Protease that cleaves GSDMD and pro-IL-1beta/IL-18 | Core executioner of pyroptosis |
| GSDMD | Pore-forming protein activated by caspase-1/4/11 | Key therapeutic target and biomarker |
| GSDME | Pore-forming protein activated by granzymes or caspase-3 | Mediates pyroptosis in specific contexts |
| IL1B | Pyrogenic cytokine matured by caspase-1 | Major mediator of inflammation |
| IL18 | Pyrogenic cytokine matured by caspase-1 | Mediator of inflammation and immune regulation |
| CASP4 | Directly activates gasdermins in response to LPS | Non-canonical inflammasome pathway |
| CASP8 | Cleaves GSDMD and drives lytic pyroptosis | Alternative activation route |
| STING1 | Senses cytosolic DNA and activates NLRP3 | Links mitochondrial stress to pyroptosis |
| CGAS | Synthesizes cGAMP to activate STING | Upstream of STING-NLRP3 axis |
| TNF | Cytokine that can switch efferocytosis to pyroptosis | Regulates cell fate decisions |
| GZMB | Granzyme that can activate gasdermins | Alternative activation mechanism |
| GZMA | Granzyme that can activate gasdermins | Alternative activation mechanism |
| AIM2 | Inflammasome sensor for cytosolic DNA | Initiates caspase-1 activation |
| NLRC4 | Inflammasome sensor for bacterial flagellin | Initiates caspase-1 activation |
| PYCARD | Adaptor protein for inflammasome assembly | Essential for caspase-1 recruitment |
How Is pyroptotic inflammatory response Regulated?
The pyroptotic inflammatory response is tightly regulated at multiple levels. Inflammasome assembly is controlled by the availability of sensors, adaptors, and post-translational modifications. Gasdermin activity is regulated by proteolytic cleavage, and emerging evidence shows that gasdermin D pore blockers can delay pyroptosis and mitigate inflammatory responses. The cGAS-STING-NLRP3 axis links mitochondrial DNA release to pyroptosis, providing a regulatory node that integrates cellular stress. Additionally, TNF signaling can switch homeostatic efferocytosis to lytic caspase-8-dependent pyroptosis, demonstrating cytokine-mediated regulation. The ribotoxic stress response also drives acute inflammation and cell death in vivo, further highlighting the diversity of regulatory inputs.
pyroptotic inflammatory response and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NLRP3 | Inflammatory diseases, cancer | NLRP3 knockout mice or cell lines |
| GSDMD | Sepsis, inflammatory bowel disease | GSDMD knockout and point-mutation models |
| CASP1 | Autoinflammatory syndromes | CASP1 knockout macrophages |
| IL1B | Gout, atherosclerosis | IL1B knock-in reporter mice |
| STING1 | Intervertebral disc degeneration | STING1 knockout nucleus pulposus cells |
Pyroptosis in Inflammatory Diseases
Dysregulated pyroptotic inflammatory response is a major driver of inflammatory diseases, including sepsis, inflammatory bowel disease, and gout. Excessive IL-1beta and IL-18 release and gasdermin-mediated cell death contribute to tissue damage and chronic inflammation. Targeting gasdermin D pores has emerged as a therapeutic strategy to mitigate these conditions.
Pyroptosis in Cancer
GO:0070269 plays a complex role in cancer, where pyroptosis can either suppress tumor growth by inducing immunogenic cell death or promote tumor progression through chronic inflammation. Modulating pyroptosis is being explored as a therapeutic approach in various malignancies.
Pyroptosis in Tissue Damage and Stress Responses
Mitochondrial DNA release triggers cGAS-STING-NLRP3-dependent pyroptosis, linking cellular stress to inflammation in conditions such as intervertebral disc degeneration. UV irradiation activates the ribotoxic stress response, which drives acute inflammation and cell death in skin, highlighting environmental triggers of pyroptosis.
From pyroptotic inflammatory response-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GSDMD mediate pyroptosis in macrophages? | GSDMD knockout cell line |
| Does a specific caspase-1 mutation affect IL-1beta maturation? | CASP1 point-mutation knock-in |
| Can we track gasdermin pore formation in real time? | GSDMD tagged knock-in with fluorescent reporter |
| Does overexpression of NLRP3 enhance pyroptosis? | NLRP3 overexpression cell line |
| What is the role of caspase-8 in TNF-induced pyroptosis? | CASP8 knockout and rescue models |
| Does mitochondrial DNA trigger STING-dependent pyroptosis? | STING1 knockout cells treated with mtDNA |
How to Study the pyroptotic inflammatory response Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality for pyroptosis | Discovery of novel regulators |
| RNA-seq | Transcriptional changes | Gene expression profiling |
| Proteomics | Protein cleavage and abundance | Gasdermin and cytokine processing |
| ELISA | IL-1beta and IL-18 secretion | Quantifying inflammatory response |
| Live-cell imaging | Pore formation and membrane rupture | Real-time pyroptosis monitoring |
| Flow cytometry | Cell death and cytokine release | Quantifying pyroptotic cells |
| Western blot | Gasdermin cleavage | Confirming pathway activation |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that regulate pyroptotic inflammatory response, such as those involved in inflammasome assembly or gasdermin activation. These screens are powerful for discovering novel regulators and potential therapeutic targets.
RNA Sequencing and Transcriptomics
RNA-seq can reveal transcriptional changes during pyroptosis, including upregulation of inflammatory cytokines and gasdermin family members. This approach helps define the gene expression signature of GO:0070269 in different cell types.
Proteomics and Cytokine Profiling
Mass spectrometry-based proteomics and cytokine arrays can quantify IL-1beta and IL-18 release, as well as gasdermin cleavage products. These methods are essential for confirming pathway activation.
Imaging and Cell Death Assays
Live-cell imaging with fluorescently tagged gasdermins and membrane integrity dyes allows real-time visualization of pore formation and pyroptotic lysis. These assays are critical for distinguishing pyroptosis from apoptosis.
How CRISPR Can Be Used to Study GO:0070269 pyroptotic inflammatory response
Knockout
CRISPR knockout of genes such as GSDMD, CASP1, or NLRP3 is widely used to test their requirement for pyroptotic inflammatory response. Knockout cell lines provide clean genetic models to dissect pathway components.
Point Mutation
Point mutations can be introduced to study specific residues critical for gasdermin pore formation or caspase activity. For example, mutating the cleavage site in GSDMD prevents its activation and pyroptosis.
Knock-in
Knock-in of tagged versions of gasdermins or caspases allows real-time tracking and localization studies. Reporter knock-ins can also be used to monitor IL-1beta secretion.
Overexpression
Overexpression of NLRP3 or gasdermins can sensitize cells to pyroptosis and is useful for gain-of-function studies. This approach helps identify downstream effects and potential therapeutic targets.
How EDITGENE Supports pyroptotic inflammatory response Research
Researchers studying pyroptotic inflammatory response-related genes often need to determine whether a candidate gene is causally involved in pathway activation, cytokine release, or cell death. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for pyroptotic inflammatory response research.
Frequently Asked Questions About pyroptotic inflammatory response
What is pyroptotic inflammatory response (GO:0070269)?
It is a gasdermin-dependent inflammatory response associated with the generation of pyrogenic mediators such as IL-1beta and IL-18, and in some cells leads to pyroptotic programmed cell death.
What genes are involved in pyroptotic inflammatory response?
Key genes include NLRP3, CASP1, GSDMD, GSDME, IL1B, IL18, CASP4, CASP8, STING1, and CGAS.
How is pyroptosis activated?
Gasdermins are activated by caspase-1 or caspase-4/11, or by certain granzymes, leading to pore formation and cytokine release.
What is the difference between pyroptosis and apoptosis?
Pyroptosis is a lytic, inflammatory form of cell death mediated by gasdermins, whereas apoptosis is typically non-lytic and non-inflammatory.
What diseases are associated with pyroptosis?
Pyroptosis is implicated in inflammatory diseases, cancer, tissue damage, and stress responses such as UV-induced skin inflammation.
Can pyroptosis be therapeutically targeted?
Yes, gasdermin D pore blockers and other inhibitors are being developed to mitigate inflammatory responses.
What role does caspase-8 play in pyroptosis?
Caspase-8 can cleave gasdermin D and drive lytic pyroptosis and IL-1beta maturation, particularly in TNF signaling contexts.
How is mitochondrial DNA linked to pyroptosis?
Cytosolic escape of mitochondrial DNA triggers the cGAS-STING-NLRP3 axis, leading to pyroptosis.
What experimental models are used to study pyroptosis?
CRISPR knockout, knock-in, overexpression cell lines, and animal models are commonly used.
What methods are used to measure pyroptosis?
ELISA, Western blot, live-cell imaging, flow cytometry, and RNA-seq are standard methods.
Conclusion
The pyroptotic inflammatory response (GO:0070269) is a fundamental innate immune pathway that integrates inflammasome sensing, gasdermin activation, and cytokine release to drive inflammation and cell death. Its dysregulation is linked to a wide range of diseases, making it a high-priority target for therapeutic intervention. Continued research using advanced CRISPR models and multi-omics approaches will further elucidate its mechanisms and translational potential.
References
- 1. Rao Z et al.. 2022. Pyroptosis in inflammatory diseases and cancer.. Theranostics 12(9):4310-4329 PMID: 35673561
- 2. Sun J et al.. 2025. Delaying pyroptosis with an AI-screened gasdermin D pore blocker mitigates inflammatory response.. Nat Immunol 26(10):1660-1672 PMID: 40954252
- 3. Broz P et al.. 2016. Inflammasomes: mechanism of assembly, regulation and signalling.. Nat Rev Immunol 16(7):407-20 PMID: 27291964
- 4. Vasudevan SO et al.. 2023. Pyroptosis-induced inflammation and tissue damage.. Semin Immunol 69:101781 PMID: 37352727
- 5. Bai Y et al.. 2025. Mechanistic insights into gasdermin-mediated pyroptosis.. Nat Rev Mol Cell Biol 26(7):501-521 PMID: 40128620
- 6. Zhang W et al.. 2022. Cytosolic escape of mitochondrial DNA triggers cGAS-STING-NLRP3 axis-dependent nucleus pulposus cell pyroptosis.. Exp Mol Med 54(2):129-142 PMID: 35145201
- 7. Muendlein HI et al.. 2025. TNF switches homeostatic efferocytosis to lytic caspase-8-dependent pyroptosis and IL-1β maturation.. Sci Immunol 10(108):eadq0043 PMID: 40540586
- 8. Vind AC et al.. 2024. The ribotoxic stress response drives acute inflammation, cell death, and epidermal thickening in UV-irradiated skin in vivo.. Mol Cell 84(24):4774-4789.e9 PMID: 39591967
